CReATe Podcasts h1 >
The CReATe podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases along with their family members and caregivers. At the moment there are two different series – the CReATe Author Series and the CReATe ALS Untangled Series.
In the CReATe Author Series, Dr. Nadia Sethi, director of community outreach and engagement at the ALS Therapy Development Institute, and Dr. Richard Bedlack, professor of neurology and director of the Duke ALS Clinic who is also in charge of education and outreach for CReATe, review publications they feel are of interest to the ALS community and interview the authors, many of whom are members of the CReATe Consortium. Click here to see to a list of these interviews and then click on the title to see a summary of the episode along with the recording.
In the CReATe ALS Untangled Series, Allison Bulat, the co-chair of the patient education and advocacy committee for NEALS, and Dr. Richard Bedlack, professor of neurology and director of the ALS Clinic at Duke University and founder of ALS Untangled, discuss ALS Untangled reviews. It is the aim of ALS Untangled and its multinational team to scientifically review some of the many alternative and off-label treatments for ALS in order to help people make more informed decisions. Click here to see to a list of these interviews and then click on the title to see a summary of the episode along with the recording.
CReATe Author Series
CReATe Author Series Ep. 8 Part II - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS
Dr. Martin Turner is a professor of clinical neurology & neurosciences at the University of Oxford and Dr. Michael Benatar is a professor of neurology and chief of the Neuromuscular Division and executive director of the ALS Center at the University of Miami. They will be discussing their recent publication “Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal”, and the potential role of NfL as a biomarker for ALS. This is part II of a two part series.
CReATe Author Series Ep. 8 Part I - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS
Dr. Martin Turner is a professor of clinical neurology & neurosciences at the University of Oxford and Dr. Michael Benatar is a professor of neurology and chief of the Neuromuscular Division and executive director of the ALS Center at the University of Miami. They will be discussing their recent publication “Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal”, and the potential role of NfL as a biomarker for ALS. This is part I of a two part series.
CReATe Author Series: Ep. 7 - Drs. Jim Caress and Michael Benatar on Electronic Health Records and ALS research
Dr. Jim Caress is a professor of neurology at Wake Forest University and Dr. Michael Benatar is a professor of neurology and chief of the Neuromuscular Division and executive director of the ALS Center at the University of Miami. They will be discussing their recent publication titled “Harnessing the power of the electronic health record for ALS research and quality improvement: CReATe CAPTURE-ALS and the ALS Toolkit”.
CReATe Author Series: Ep. 6 - Drs. Mary-Louise Rogers and Michael Benatar on Urine Biomarkers for ALS
Dr. Mary-Louise Rogers is an associate professor at the College of Medicine and Public Health at Flinders University and Dr. Michael Benatar is a professor of neurology and chief of the Neuromuscular Division and executive director of the ALS Center at the University of Miami. They will be discussing their recent publication titled “Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis,” which discusses the importance of biomarkers in ALS.
CReATe Author Series: Ep. 5 - Dr. Marc Weisskopf and Environmental Risk Factors in ALS
Dr. Marc Weisskopf is the Cecil K. and Philip Drinker Professor of Environmental Epidemiology and Physiology at Harvard T. H. Chan School of Public Health. In this interview, he discusses his recent publication titled “Occupational lead exposure and survival with amyotrophic lateral sclerosis,” which discusses the role that environmental risk factors could play in ALS.
CReATe Author Series: Ep. 4 - Drs. Melissa Nel and Jeannine Heckmann and African Genetic Diversity in ALS
Dr. Melissa Nel is a research fellow, and Dr. Jeannine Heckmann a professor of neurology, both at the University of Cape Town in South Africa. In this interview, they discuss their recent publication titled “Revealing the Mutational Spectrum in South Africans with Amyotrophic Lateral Sclerosis” which highlights that ALS patients of African genetic ancestry should be included in large-scale ALS gene discovery efforts.
Published: 2022-07-01 24:33
CReATe Author Series: Ep. 3 - Dr. Michael Benatar and Neurofilament Biomarkers for ALS
Dr. Michael Benatar is the Walter Bradley Chair in ALS Research, a professor of neurology at the University of Miami Miller School of Medicine and the principal investigator of the CReATe Consortium. In this interview, he will discuss the CReATe Consortium’s recent paper titled "Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS". The interview highlights the specific ways in which validated biomarkers could benefit therapeutic development for ALS.
Published: 2021-12-22 16:03:29
CReATe Author Series: Ep. 2 - Dr. Corey McMillan and Cognition in ALS
Dr. Corey McMillan is an associate professor of neurology at the University of Pennsylvania and this interview will be discussing his recent paper titled “Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis (ALS)” which discusses the contribution of genetics to heterogeneity we observe in ALS.
Published: 2021-11-05 12:45:19
CReATe Author Series: Ep. 1 - Dr. Benjamin Murdock and Immune Mechanisms in ALS
Dr. Benjamin Murdock is a research assistant professor of neurology at the University of Michigan and this interview will be discussing his recent paper titled “NK Cells associated with ALS in a sex- and age-dependent manner” which further expands his ongoing research examining the impact of sex and age on immune mechanisms in ALS.
Published: 2021-10-04 17:48:18
ALS Untangled Series
ALS Untangled Series Ep. 56 - Sodium Chlorite
Sodium chlorite is an experimental drug targeting macrophage activation. It exists in different formulations. An oral formulation has potentially deadly side effects. An IV formulation called NP001 has been in recent trials targeting a subset of people with ALS. Here we review the interesting development of this product and where we expect that to go in the near future.
Published: 2023-1-15 00:11:00
ALS Untangled Series Ep. 55 - Rituximab
Rituximab is an intravenous product that reduces B lymphocytes. It can help improve strength in patients with myasthenia gravis and multi-focal motor neuropathy, neuromuscular diseases that are caused by circulating antibodies made by B lymphocytes. In this podcast we examine the possible use of rituximab to treat patients with ALS.
Published: 2023-10-09 15:07:48
ALS Untangled Series Ep. 54 - Ozone Therapy
Ozone is an oxidizing agent which has some surprisingly plausible mechanisms by which it could influence ALS progression. It can also be dangerous. The FDA has warned against using it as a treatment for any disease. Further studies are needed to determine whether there is any dose or route of administration that might be safe and effective for use in people with ALS.
Published: 2023-09-05 11:00:25
ALS Untangled Series Ep. 53 - Astaxanthin
Astaxanthin is a naturally occurring chemical which has plausible mechanisms for treating ALS and appears reasonably safe and well tolerated in non-ALS trials. We look forward to ALS-specific trials planned later this year which should shed important light on whether this is specifically safe for people with ALS, and whether it really can slow ALS progression.
Published: 2023-08-08 11:43:48
ALS Untangled Series: Ep. 52 - Antimycobacterial Antibiotics
There is a theorized association between mycobateria and ALS, and two published case reports describe improvements in ALS-like conditions (both with atypical features) after treatment with antimycobaterial antibiotics. Here we review these in detail and discuss our thoughts on how they might change our approach in certain patients in the future.
ALS Untangled Series Ep. 51 – Corticosteroids
Corticosteroids are a class of medications with well-studied effects on the immune system and some people living with ALS have reported benefits from them online. Here we review the pre-clinical and clinical data. We conclude that there is currently no clear evidence that steroids can slow ALS progression, and they can have many side effects.
ALS Untangled Series Ep. 50 – Butyrate
Butyrates have plausible mechanisms for slowing ALS progression and positive pre-clinical studies. One trial suggests that sodium phenylbutyrate (NaPB) in combination with Tauroursodeoxycholic acid (TUDCA) can slow ALS progression and prolong survival, but the specific contribution of NaPB toward this effect is unclear. Butyrates appear reasonably safe for use in humans. Based on the above information, we support a trial of a butyrate in PALS, but we cannot yet recommend one as a treatment.
ALS Untangled Series Ep. 49 – Methylcobalamin
Methylcobalamin is a specific precursor to B12 (cobalamin). It has promising mechanisms by which it could slow ALS progression. Two trials done in Japan suggest that 50mg via intramuscular injection twice weekly can slow ALS progression and prolong survival. Here we discuss the evidence for ultra-high dose methylcobalamin in patients with ALS and conclude that it may offer benefit, but only if administered within the first year of symptoms. If started after the first year, there is no evidence of benefit. It appears reasonably safe.
ALS Untangled Series Ep. 48 - Vitamin C
Vitamin C is a very popular supplement in people living with ALS, perhaps due to its antioxidant mechanism, low cost, and low risk. Here we review the data on Vitamin C in ALS in hopes of helping patients make more informed decisions about it.
ALS Untangled Series Ep. 47 - Melatonin
Melatonin is a naturally occurring hormone, and it is commonly taken as a supplement to induce sleep. Here we review some surprising mechanisms, pre-clinical data and case reports supporting its potential as an ALS treatment.
ALS Untangled Series Ep. 46 - Light Therapy
Light therapy has surprisingly plausible mechanisms through which it could influence the progression of ALS. Here we describe these, as well as some limited pre-clinical and clinical data, and information about dosing, risks, and costs.
ALS Untangled Series: Ep. 45 - Ketogenic Diets
Ketogenic diets, resulting in the formation of ketone bodies, have long been used to promote weight loss and to treat refractory epilepsy. Here we summarize the available data on ketogenic diets as a treatment for ALS.
ALS Untangled Series: Ep. 44 - Tamoxifen
Tamoxifen is an FDA approved estrogen receptor modulator that is currently prescribed to treat breast cancer. Here we review surprising evidence that it could someday be an ALS treatment, including its mechanisms of action, pre-clinical data, cases, trials, and risks.
Published: 2021-07-06 20:06:39
ALS Untangled Series: Ep. 43 - Spirulina (blue green algae)
Spirulina, or blue green algae, is a supplement that is claimed to have antioxidant and anti-inflammatory properties. Here we review the problems we found with the single relevant preclinical ALS study, and some surprising real and potential risks associated with this product.
Published: 2021-06-08 15:00:25
ALS Untangled Series: Ep. 42 - Lutimax
Lutimax is a supplement containing Luteolin, a flavonoid that has antioxidant, anti-inflammatory and neuroprotective mechanisms. Here we review case reports and a small trial claiming benefits in people with ALS.
Published: 2021-05-21 19:24:53
ALS Untangled Series: Ep. 41 - Bee Venom
Bee Venom contains substances that could plausibly affect the rate of ALS progression, and there are some positive (though flawed) preclinical studies and case reports associated with it. Since it has some potentially severe side effects and has not been tested in an ALS trial, our group advised against using it to try and slow ALS progression.
Published: 2021-04-29 16:58:40
ALS Untangled Series: Ep. 40 - Vinpocetine
Vinpocetine is a prescription drug in many countries and is used to treat patients with stroke and memory loss (though meta-analyses have questioned its benefit in these populations). In the USA, it is sold as a nutritional supplement. Here we review the potential mechanisms, data from pre-clinical models, case reports, and a trial, and the safety of vinpocetine as an ALS treatment.
Published: 2021-01-25 13:58:51
ALS Untangled Series: Ep. 39 - Apoaequorin (Prevagen)
Apoaequorin (also called Prevagen) is a calcium-binding protein first isolated from jellyfish. Here we review the theory and the single trial of this compound for treating ALS.
Published: 2021-01-07 16:10:11
ALS Untangled Series: Ep. 38 - Azathioprine
Azathioprine is an immunosuppressant drug. Here we review the mechanisms by which it could slow ALS progression, discuss the ALS reversals and the negative ALS trials associated with this drug, and highlight some of the serious side effects that can occur in patients taking it.
Published: 2020-12-17 18:54:22
ALS Untangled Series: Ep. 37 - Accilion
Accilion is a topical mineral cream. Here we discuss why we do not think it has a plausible mechanism of action for treating ALS. We also point out the problems interpreting the one anecdotal report of improvement in ALS symptoms associated with this treatment.
Published: 2020-11-30 18:29:02
ALS Untangled Series: Ep. 36 - Vitamin E
Vitamin E is one of the most popular, and most thoroughly studied, supplements in patients with ALS. Although it is inexpensive and safe, well-designed trials have failed to find evidence that it can slow, stop, or reverse ALS progression. Interestingly, some data suggest that long-term use of vitamin E might decrease a person's risk of getting ALS.
Published: 2020-10-05 14:13:27
ALS Untangled Series: Ep. 35 - Leap2Bfit
Leap2Bfit is a combination of many ingredients. The exact amount of each ingredient is not clear. While some of these products have plausible mechanisms and preclinical studies supporting their use in ALS, others do not. There are 3 "ALS reversals" associated with this product, but these may have different explanations. Several other patients under the care of ALS Untangled investigators have derived no clear benefit from this product. There can be serious risks associated with some of the ingredients in this product.
Published: 2020-09-17 17:37:16
ALS Untangled Series: Ep. 34 - Ursodiol
Ursodiol or ursodeoxycholic acid (UDCA) is a bile acid derivative of cholesterol. Since it can have antioxidant, anti-inflammatory and anti-apoptotic effects, it has mechanisms by which it could slow ALS progression. Here we discuss trials of UDCA in PALS, including the taurine-conjugated form (TUDCA). Some of these trials came out after our ALS Untangled review, and have changed our opinion about UDCA as an ALS treatment.
Published: 2020-08-22 13:42:14
ALS Untangled Series: Ep. 33 - Propofol
Propofol is an intravenous drug used for general anesthesia. Some people with ALS have reported benefits from this drug. Here we explore the rationale, the cases we found objective data on, and the serious risks of propofol as an ALS treatment.
Published: 2020-08-03 15:49:12
ALS Untangled Series: Ep. 32 - L-Carnitine
Carnitines are inexpensive, generally safe forms of amino acids. There are several mechanisms by which different carnitines might theoretically be helpful to a person with ALS. A flawed Italian trial suggested that acetyl-L-carnitine could slow ALS progression. Here we examine carnitines in more detail in hopes of helping patients with ALS make more informed decisions about them.
Published: 2020-07-10 21:32:53
ALS Untangled Series: Ep. 31 – Gluten-free diet
Gluten is a protein found in breads and cereals. In a small percentage of people, ingestion of gluten can trigger an autoimmune disease. Here we review the evidence that gluten-induced autoimmunity can mimic ALS, as well as the pros and cons of a gluten-free diet for people with ALS.
Published: 2020-06-04 03:53:57
ALS Untangled Series: Ep. 30 – Mito Q
It is clear that oxidative stress is occurring in the brains and spinal cords of patients with ALS. The mitochondria are a major source and target of this oxidative stress. Here we describe an antioxidant that specifically targets mitochondria called MitoQ.
Published: 2020-05-27 19:44:27
ALS Untangled Series: Ep. 29 – Fecal Transplants
There is increasing evidence that the microbiome (the family of organisms that live in our guts) may play a role in driving ALS progression. Here we review the evidence behind that idea, and explore fecal transplants as one potential way to alter the microbiome.
Published: 2020-05-27 19:44:18
ALS Untangled Series: Ep. 28 - List of rotten eggs
This is a list of a dozen things to watch out for when considering an alternative or off label treatment being advertised on the Internet. These things tend to be associated with some of the less promising treatments that ALS Untangled has reviewed over the past 11 years. The more of these things one finds associated with a product, the more wary we think they should be about it.
Published: 2020-05-27 19:44:05
ALS Untangled Series: Ep. 27-Glutathione
Glutathione is one of the major antioxidants in all our cells. It is also one of the most popular supplements taken by patients with ALS around the world. Here we review what we learned about the mechanisms of action, pre-clinical data, case reports, trials and risks of taking glutathione for ALS.
Published: 2020-02-28 16:22:45
ALS Untangled Series: Ep. 26 - Vitamin D
Many patients with ALS have low vitamin D levels. Here we discuss ways that vitamin D might be important in slowing ALS progression, and in reducing the risk of bone fractures from falls. We explain why we think it is important for patients with ALS to have their vitamin D levels checked, and if these levels are low, to get them into the normal range.
Published: 2020-02-07 15:41:40
ALS Untangled Series: Ep. 25 - Rife Machine and Retroviruses
In the 1930s, Royal Raymond Rife developed special microscopes he claimed he could visualize living microorganisms, including viruses too small to be seen with any other existing technology, via the color of auras emitted as they vibrated. He also claimed to have developed a machine that used radio waves to kill these organisms. While the use of radio waves to treat disease (a field called "radionics") has been debunked by scientists, it turns out that tiny organisms called retroviruses may actually play a role in causing some cases of ALS.
Published: 2020-02-07 15:41:35
ALS Untangled Series: Ep. 24 - “When ALS is Lyme”
Here we review an online manuscript called “When ALS is Lyme.” As in our previous ALS Untangled review, our large international team of clinicians and scientists again finds no convincing scientific evidence for a connection between Lyme disease and ALS.
Published: 2019-11-13 16:28:13
ALS Untangled Series: Ep. 23 - Hyperbaric Oxygen
Hyperbaric oxygen can increase heat shock proteins, which might be useful in decreasing oxidative stress and protein aggregation in ALS. It looked promising in animal models of ALS, and is associated with 1 validated case of “ALS reversal.” Unfortunately a clinical trial in patients with ALS showed no benefit and this can cause serious side effects.
Published: 2019-11-13 16:28:10
ALS Untangled Series: Ep. 22 - Ayahuasca
Ayahuasca is a hallucinogen used in religious rituals in the Amazon. This podcast reviews the potential mechanisms by which it might slow the progression of ALS, as well as a few case reports suggesting benefit. Unfortunately we learned this product can cause death and/or hospitalization.
Published: 2019-11-13 16:28:05
ALS Untangled Series: Ep. 21 - Anti-fungals
One group has reported evidence of fungal infections in the brains of patients who died from ALS. Here we explore the potential explanations for this finding, and the potential for anti-fungal medications as an ALS treatment.
Published: 2019-11-13 16:28:01
ALS Untangled Series: Ep. 20 – Resveratrol
Resveratrol is a naturally occurring chemical found in grapes, berries and peanuts. By modulating sirtuins, protein aggregation and the gut microbiome, it could theoretically slow ALS progression. We describe an animal study and an "ALS Reversal" that provide some support for this idea.
Published: 2019-07-17 16:19:43
ALS Untangled Series: Ep. 19 – RT001
Oxidative stress is widely believed to be one of the molecular pathways driving ALS progression. Many different antioxidants have been tried in people with ALS, with little or no previous benefit. RT001 fights oxidative stress in a unique way. Here we show why this might be more effective than other antioxidants and review some very early data from the RT001 expanded access program.
Published: 2019-07-17 16:19:40
ALS Untangled Series: Ep. 18 – Penicillin G/Hydrocortisone
Penicillin G is an antibiotic and hydrocortisone is an anti-inflammatory. These 2 drugs have been successfully used in combination to treat cases of syphilis mimicking ALS. Here we show 1 person's theory on why they could help people with ALS who do not have syphilis, and critique some of his case reports.
Published: 2019-07-17 16:19:36
ALS Untangled Series: Ep. 17 – Perampanel
Perampanel (also called Fycompa) is a drug used to treat epileptic seizures. Here we review the reasons it might be useful in slowing ALS progression and describe what happened when ALS mice and a small number of people with ALS were treated with this and similar drugs. We describe the ongoing ALS trials and review safety and dosing considerations.
Published: 2019-07-17 16:19:31
ALS Untangled Series: Ep. 16 – Acupuncture
Acupuncture is often thought of as a treatment option for pain. In this podcast we look critically at whether acupuncture might have mechanisms that could slow ALS progression, and we review published trials of acupuncture in patients with ALS.
Published: 2018-12-20 12:51:46
ALS Untangled Series: Ep. 15 – Low dose naltrexone for ALS
Low dose naltrexone (LDN) has been proposed as a treatment for a long list of different diseases. Here we examine the potential mechanisms, pre-clinical data and anecdotal reports on LDN in ALS.
Published: 2018-12-20 12:51:43
ALS Untangled Series: Ep. 14 – Cannabis
Many patients over the years have told us that forms of cannabis can help bothersome ALS symptoms such as pain, cramps, fasciculations, and low appetite. Here we review theoretical, pre-clinical and anecdotal evidence that forms of cannabis might slow the progression of ALS.
Published: 2018-12-20 12:51:38
ALS Untangled Series: Ep. 13 – Antiretrovirals
Several observations suggest that retroviruses might be able to kill motor neurons, causing forms of ALS. Here we review these data, focusing on the theory that reactivation of an "endogenous" retrovirus we all have hiding in our genes called Herv-K might cause some cases of sporadic ALS. We examine drugs that attack retroviruses as potential treatments for patients with ALS.
Published: 2018-12-20 12:51:32
ALS Untangled Series: Ep. 12 - Deanna Protocol
With more than 30,000 downloads, this remains our most popular ALS Untangled review of all time. Here we review the history and evolution of this cocktail, including what has been learned about it since we published our review. We highlight the problems with interpreting unverified anecdotal data in ALS.
Published: 2018-06-12 14:39:32
ALS Untangled Series: Ep. 11 - Protandim
Protandim is an oral tablet derived from 5 different plants, which may be able to activate an antioxidant pathway in cells. This treatment is also associated with an “ALS reversal,” appears reasonably safe and inexpensive, and warrants further study in people with ALS.
Published: 2018-06-12 14:38:34
ALS Untangled Series: Ep. 10 - Lunasin
Lunasin, a peptide first isolated from soybeans, is associated with an “ALS reversal.” We explain why we once had great hope for this as an ALS treatment. We then review the results from a recently-completed, year-long clinical trial of Lunasin in 50 people with ALS. Unfortunately, no one in this trial had an ALS reversal or even any detectable slowing of their progression, and there were unexpected GI side effects including constipation severe enough to warrant hospitalization.
Published: 2018-06-12 14:37:48
ALS Untangled Series: Ep. 9 - Coconut Oil
Once ingested, coconut oil gets converted to ketone bodies which might be able to help central nervous system cells produce more normal levels of energy, and be more resistant to ALS. Here we discuss the potential utility of coconut oil and other ways to elevate ketone bodies in the treatment of ALS, including an upcoming trial of Triheptanoin.
Published: 2018-06-12 14:37:03
ALS Untangled Series: Ep. 8 - L-serine
BMAA is a toxin that may cause some forms of sporadic ALS. Here we discuss how L-serine, an inexpensive, widely available amino acid supplement, might block BMAA toxicity and thus be of use for preventing or slowing ALS progression.
Published: 2018-04-13 17:38:57
ALS Untangled Series: Ep. 7 - Acuscope
Acuscope is a machine that delivers a very small amount of electric current to muscles. In this podcast we report that acuscope treatment appears fairly safe, but is expensive and has shown no clear benefit in slowing ALS.
Published: 2018-04-13 17:38:53
ALS Untangled Series: Ep. 6 - Curcumin
Curcumin is an ingredient in the spice tumeric and in curry powder. It has multiple plausible mechanisms by which it might slow ALS progression. There are 3 people with validated ALS diagnoses who recovered significant lost motor function (ALS reversals) on forms of it. Here we discuss the specific curcumin formulation and dosage that we think is promising enough to warrant further study in ALS.
Published: 2018-04-13 17:38:43
ALS Untangled Series: Ep. 5 - Inosine
Inosine is a naturally occurring oral supplement that raises blood urate levels. In this podcast, we discuss ways this might slow ALS progression and why it needs careful blood and urine monitoring.
Published: 2018-04-13 17:38:35
ALS Untangled Series: Ep. 4 - Copper
CuATSM is a very promising ALS treatment that is in development. Here we discuss copper metabolism in ALS, why this specific therapy might help and why less complicated copper supplements are unlikely to be of any benefit.
Published: 2018-03-07 15:08:08
ALS Untangled Series: Ep. 3 - Elysium health’s “Basis” therapy
Basis in an over the counter supplement containing nicotinamide ribose and pterostilbene. In this podcast, we review the theories on how this might help a person with ALS, as well as the potential risks and costs involved.
Published: 2018-03-07 15:08:01
ALS Untangled Series: Ep. 2 - Eric is Winning
In this podcast, we discuss one of the most requested ALS Untangled reviews of all time-a complicated treatment cocktail described in a book written by a patient with slowly progressive ALS called "Eric is Winning."
Published: 2018-03-07 15:07:55
ALS Untangled Series: Ep. 1 - ALS Untangled
ALS Untangled is an internet based program that reviews alternative and off label treatments, with the goal of helping people with ALS make more informed decisions about them. This podcast describes how the program works.
Published: 2018-03-07 15:07:48